课题基金 / 基金详情

Computational Design, Bioinformatics & Screening

Computational Design, Bioinformatics & Screening
计算设计、生物信息学
批准号:
6940588
负责人:
Michael E. Johnson
金额:
$33.44万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31

项目摘要

项目成果

Michael E. Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this Core is to provide computational, bioinformatics and high throughput screening support for all three Projects. Computational support will include continued computer-aided design of new and/or improved inhibitors against SARS-CoV SCLpro and QSAR analysis of SCLpro inhibitor structures and activities to provide guidance in synthetic design (Project 3). Bioinformatics development of theoretical models for the 3-D structure of PLpro will be used as an initial foundation for PLpro structure-function studies (Project 1), for enzymatic mechanistic studies (Project 2) and for in silico screening of large chemical libraries for potential lead compounds (Projects). High throughput experimental screening will be used for initial lead discovery of PLpro inhibitors for Project 3; high throughput assays will be used for analysis of enzymatic mechanisms in Project 2. Bioinformatic analysis and modeling of protein substrate and protein-inhibitor interactions will be used to suggest particular mutations for hypothesis testing for enzymatic activity and mechanisms (Projects 1 and 2), and to predict inhibitor designs that will be least subject to mutational 'evasion'. This Core will thus provide centralized computational and high throughput assay screening for all three Projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors
  • 批准号:
    8714871
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2014
  • 负责人:
    Michael E. Johnson
  • 依托单位:
Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors
  • 批准号:
    8874893
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2014
  • 负责人:
    Michael E. Johnson
  • 依托单位:
Development of PLpro and 3CLpro Protease Inhibitors as Novel SARS Therapeutics
  • 批准号:
    8083292
  • 项目类别:
  • 资助金额:
    $151.7万
  • 财政年份:
    2010
  • 负责人:
    Michael E. Johnson
  • 依托单位:
Novel antiobiotic development for biodefense
  • 批准号:
    7932894
  • 项目类别:
  • 资助金额:
    $199.16万
  • 财政年份:
    2009
  • 负责人:
    Michael E. Johnson
  • 依托单位:
海外基金